29th June 2021
Consilium Strategic Communications Advises CMR Surgical on $600 Million Series D Financing
~ The largest ever MedTech private financing round worldwide ~
London, 29 June 2021, Consilium Strategic Communications (Consilium), a global leader in strategic healthcare communications and investor relations, is pleased to have supported CMR Surgical on the communication of its $600 million (£425 million) Series D financing. The round was led by SoftBank Vision Fund 2 and co-led by Ally Bridge Group and supported by other new international and existing investors.
CMR works with surgeons and hospitals to provide an optimal tool to make robotic keyhole surgery universally accessible and affordable. Versius’ size, portability and versatility have made it very popular with hospitals and surgeons around the world. As part of CMR’s ongoing international expansion, Versius has been successfully launched in multiple geographies worldwide including across Europe, Australia, India and the Middle East. Global demand for CMR’s surgical robot continues to grow with significant further momentum anticipated.
“It is fantastic to see a fundraise of this magnitude which is testament to not only the overall excellence of Versius, but to the whole team at CMR. We have a long-standing relationship with the company and have enjoyed watching it evolve into one of the world’s most disruptive medical devices company.”
Mary-Jane ElliottManaging Partner at Consilium Strategic Communications
“This latest fundraise, the largest ever MedTech private financing round worldwide, equips CMR with significant funds to accelerate our mission of bringing Versius to hospitals worldwide. Thank you to the professional team at Consilium for their strategic advice as we have communicated this news globally. We are looking forward to continuing our close relationship with Consilium as we execute our business strategy.”
Per Vegard NersethChief Executive Officer of CMR
The funds raised will be used to rapidly accelerate CMR’s geographical expansion and builds upon the framework the company has established to grow a long-term independent global business. The new funds will also support the continued development of the system’s digital framework, including new technological developments such as Versius Connect, an app for surgeons using the Versius surgical robotic system.
The Consilium team was led by Mary-Jane Elliott and supported by Angela Gray, Lindsey Neville and Alexander Bridge. J.P. Morgan acted as sole placement agent on CMR Surgical’s Series D financing.
To view CMR’s announcement, please click here.
For more information, please contact:
Consilium Strategic Communications
Mary-Jane Elliott / Amber Fennell
Tel: +44(0)20 3709 5700
Follow us: @consiliumhc
About Consilium Strategic Communications
Consilium Strategic Communications is a global leader in strategic healthcare communications and investor relations advisory with offices in Europe and across the US. Consilium's highly skilled team provides strategic, long-term advice to healthcare companies, Boards, senior decision makers and executives on critical communications and IR programmes and stakeholder challenges. The Company has established deep knowledge across all areas of the global healthcare sector through broad experience in representing international clients spanning the Fortune 500, FTSE 100, FTSEurofirst 300 and FTSE 250, through to discrete specialist reputation management projects.
The Versius Surgical Robotic System
Versius® resets expectations of robotic surgery. Versius fits into virtually any operating room set-up and integrates seamlessly into existing workflows, increasing the likelihood of robotic minimal access surgery (MAS). The portable and modular design of Versius allows the surgeon to only use the number of arms needed for a given procedure.
Biomimicking the human arm, Versius gives surgeons the choice of optimised port placement alongside the dexterity and accuracy of small fully-wristed instruments. With 3D HD vision, easy-to adopt instrument control and a choice of ergonomic working positions, the open surgeon console has the potential to reduce stress and fatigue and allows for clear communication with the surgical team. By thinking laparoscopically and operating robotically with Versius, patients, surgeons and healthcare professionals can all benefit from the value that robotic MAS brings.
But it’s more than just a robot. Versius captures meaningful data with its wider digital ecosystem to support a surgeon’s continuous learning. Through the Versius Connect app, Versius Trainer and CMR clinical registry, Versius unleashes a wealth of insights to ultimately improve surgical care.
About CMR Surgical Limited
CMR Surgical (CMR) is a global medical devices company dedicated to transforming surgery with Versius®, a next-generation surgical robot.
Headquartered in Cambridge, United Kingdom, CMR is committed to working with surgeons, surgical teams and hospital partners, to provide an optimal tool to make robotic minimal access surgery universally accessible and affordable. With Versius, we are on a mission to redefine the surgical robotics market with practical, innovative technology and data that can improve surgical care.
Founded in 2014, CMR Surgical is a private limited company backed by an international shareholder base.